Bosh sahifaCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
Yopilish kursi
151,63 $
Kunlik diapazon
149,80 $ - 152,63 $
Yillik diapazon
91,86 $ - 254,15 $
Bozor kapitalizatsiyasi
7,45 mlrd USD
Oʻrtacha hajm
903,75 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NYSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(USD) | mar, 2025info | Y/Y qiyosi |
---|---|---|
Daromad | 984,17 mln | -2,71% |
Joriy xarajat | 206,08 mln | -1,77% |
Sof foyda | 25,47 mln | -62,17% |
Sof foyda marjasi | 2,59 | -61,11% |
Har bir ulushga tushum | 2,34 | 3,08% |
EBITDA | 218,88 mln | -4,14% |
Amaldagi soliq stavkasi | 28,07% | — |
Balans
Jami aktivlari
Jami passivlari
(USD) | mar, 2025info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 229,36 mln | -29,87% |
Jami aktivlari | 7,58 mlrd | -7,00% |
Jami passivlari | 4,34 mlrd | -2,43% |
Umumiy kapital | 3,24 mlrd | — |
Tarqatilgan aksiyalar | 49,12 mln | — |
Narxi/balansdagi bahosi | 2,33 | — |
Aktivlardan daromad | 4,43% | — |
Kapitaldan daromad | 5,35% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(USD) | mar, 2025info | Y/Y qiyosi |
---|---|---|
Sof foyda | 25,47 mln | -62,17% |
Operatsiyalardan naqd pul | 171,70 mln | 32,19% |
Sarmoyadan naqd pul | -45,48 mln | 46,99% |
Moliyadan naqd pul | -105,32 mln | -674,10% |
Naqd pulning sof oʻzgarishi | 26,16 mln | -51,61% |
Boʻsh pul | 147,04 mln | 279,41% |
Haqida
Charles River Laboratories International, Inc. is an American pharmaceutical company specializing in preclinical and clinical laboratory, gene therapy and cell therapy services and supplies for the pharmaceutical, medical device and biotechnology industries.
The company has over 150 facilities, operates in 21 countries, and employs over 21,000 people worldwide.
Charles River Laboratories frequently criticized by animal rights activists, who condemn the company's use of dogs and primates for pharmaceutical research. The company is also a major harvester of blood from horseshoe crabs. Wikipedia
Tashkil etilgan
1947
Sayt
Xodimlar soni
19 400